Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,206.40
(
0.01%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.27
(
-0.92%
)
Bitcoin
77,871.70
(
-0.52%
)
News Focus
News Focus
Post# of 405181
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sunspotter

Send PM Follow Ignore
Followers 227
Posts 17349
Boards Moderated 5
Alias Born 06/02/2007

sunspotter

Member Level

Re: petemantx post# 368282

Monday, 08/02/2021 8:37:52 AM

Monday, August 02, 2021 8:37:52 AM

Post# of 405181
“Brilacidin actually KILLS the virus so viral load HAS to drop dramatically, and the SOC is currently near 0 (a total waste) so how could efficacy not be pronounced? “

Very easily. Just one of the ways it could fail is if its in vitro MoA is due to phospholipidosis (which has nothing to do with claims that that is ann vivo side effect as others have misunderstood).

Consider also that remdesivir is more effective than brilacidin in vitro but only marginally effective in vivo.

"Nobody ever went broke underestimating the intelligence of the
American public."

H. L. Mencken

"It’s easier to fool people than to convince them that they have been fooled."

Anon

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote